• Clin. Orthop. Relat. Res. · Nov 2010

    Multicenter Study

    Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.

    • Pietro Ruggieri, Andreas F Mavrogenis, Giuseppe Ussia, Andrea Angelini, Panayiotis J Papagelopoulos, and Mario Mercuri.
    • Department of Orthopaedics, University of Bologna, Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136, Bologna, BO, Italy. pietro.ruggieri@ior.it
    • Clin. Orthop. Relat. Res. 2010 Nov 1;468(11):2954-61.

    BackgroundThe best treatment of giant cell tumor of the sacrum is controversial. It is unclear whether adjuvant treatment with intralesional surgery reduces recurrences or increases morbidity.Questions/PurposesWe therefore asked whether adjuvants altered recurrence rates and complications after intralesional surgery for sacral giant cell tumors.MethodsWe retrospectively studied 31 patients with sacral giant cell tumors treated with intralesional surgery with and without adjuvants. Survival to local recurrence was evaluated using Kaplan-Meier analysis. The differences in survival to local recurrence with and without adjuvants were evaluated using multivariate Cox regression analysis. Complications were recorded from clinical records and images. The minimum followup was 36 months (median, 108 months; range, 36-276 months).ResultsOverall survival to local recurrence was 90% at 60 and 120 months. Survival to local recurrence with and without radiation was 91% and 89%, with and without embolization was 91% and 86%, and with and without local adjuvants was 88% and 92%, respectively. Adjuvants had no influence on local recurrence. Mortality was 6%: one patient died at 14 days postoperatively from a massive pulmonary embolism and another patient had radiation and died of a high-grade sarcoma. Fifteen of the 31 patients (48%) had one or more complications: eight patients (26%) had wound complications and seven patients (23%) had massive bleeding during curettage with hemodynamic instability. L5-S2 neurologic deficits decreased from 23% preoperatively to 13% postoperatively; S3-S4 deficits increased from 16% to 33%.ConclusionsAdjuvants did not change the likelihood of local recurrence when combined with intralesional surgery but the complication rate was high.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…